Gurung, A. B., Ali, M. A., Lee, J., Abul Farah, M., & Al-Anazi, K. M. (2020). In silico screening of FDA approved drugs reveals ergotamine and dihydroergotamine as potential coronavirus main protease enzyme inhibitors. Saudi J Biol Sci.

Gurung, Arun Bahadur, Mohammad Ajmal Ali, Joongku Lee, Mohammad Abul Farah, and Khalid Mashay Al-Anazi. "In Silico Screening of FDA Approved Drugs Reveals Ergotamine and Dihydroergotamine As Potential Coronavirus Main Protease Enzyme Inhibitors." Saudi J Biol Sci 2020.

Gurung, Arun Bahadur, et al. "In Silico Screening of FDA Approved Drugs Reveals Ergotamine and Dihydroergotamine As Potential Coronavirus Main Protease Enzyme Inhibitors." Saudi J Biol Sci 2020.